This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
32 |
4. Check minimum number of eventsNone |
32 |
5. Include endpointsNone |
32 |
6. Filter based on genotype QC (FinnGen only) |
32 |
Control definitions (FinnGen only)
- Control exclude
- ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T6[6-9]|T7[0-8]
- Name in latin
- Asphyxiatio
Similar endpoints
↥List of similar endpoints to
Asphyxiation
based on the number of shared cases.
Similar with more cases:
- Other and unspecified effects of external causes
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 32 | 13 | 19 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 63.67 | 54.95 | 69.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000991) Gas panel - Venous blood
7
18
4.66
2.41
2.0
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
13
59
3.03
2.21
3.0
3.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
28
3.46
2.03
1.5
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
17
238
0.39
1.74
4.3
5.0
mmol/l
2.5
2.5
0.15
17
221
(3016502) Oxygen saturation in Arterial blood
6
20
3.44
1.67
5.0
3.0
%
96.0
96.0
—
6
20
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
20
3.44
1.67
4.8
3.0
g/l
130.7
125.4
—
6
20
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
7
27
3.02
1.62
3.0
2.5
%
1.4
1.4
—
7
22
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
16
224
0.43
1.47
2.7
4.1
mmol/l
0.9
1.3
3.16
16
207
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
17
232
0.43
1.44
3.5
4.6
mmol/l
4.3
4.4
0.17
17
214
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
14
81
2.29
1.37
1.7
2.2
u/l
120.4
118.4
0.03
14
76
(3012544) pH of Venous blood
6
24
2.83
1.37
1.3
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
17
230
0.44
1.35
3.1
4.5
mmol/l
1.5
1.4
0.29
17
212
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.77
1.20
1.8
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
20
2.77
1.20
1.8
1.8
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
5
22
2.50
1.07
5.8
2.8
kpa
13.4
10.7
—
5
22
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
5
22
2.50
1.07
6.0
2.8
kpa
4.8
5.0
—
5
22
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
18
229
0.51
0.96
17.1
11.2
ml/min/173m2
87.4
84.5
0.27
13
188
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
18
227
0.53
0.89
4.9
5.0
mmol/l
6.5
6.0
0.58
18
209
(3000492) Spirometry study
0
26
0.00
0.82
0.0
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
24
2.28
0.78
4.4
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
11
72
1.80
0.71
2.2
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
5
89
0.48
0.68
2.2
2.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
24
268
0.58
0.66
27.6
20.6
fl
90.6
91.0
0.16
24
263
(3026361) Erythrocytes [#/volume] in Blood
24
268
0.58
0.66
27.6
20.7
e12/l
4.4
4.5
0.59
24
263
(3010813) Leukocytes [#/volume] in Blood
24
268
0.58
0.66
27.7
20.8
e9/l
7.6
6.7
1.81
24
263
(3007461) Platelets [#/volume] in Blood
24
268
0.58
0.66
27.5
20.7
e9/l
237.6
249.1
0.46
24
263
(3035941) MCH [Entitic mass]
24
268
0.58
0.66
27.5
20.5
pg
30.1
30.3
0.21
24
263
(3000963) Hemoglobin [Mass/volume] in Blood
24
268
0.58
0.66
27.8
20.8
g/l
130.0
135.8
1.01
24
263
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
34
1.94
0.63
1.7
2.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
0
20
0.00
0.63
0.0
5.5
—
1.1
—
0
7
(3021440) Promyelocytes/100 leukocytes in Blood
0
19
0.00
0.62
0.0
5.8
—
0.3
—
0
6
(3025159) Blasts/100 leukocytes in Blood
0
19
0.00
0.62
0.0
5.7
—
1.3
—
0
6
(3002179) Metamyelocytes/100 leukocytes in Blood
0
19
0.00
0.62
0.0
5.4
—
0.5
—
0
6
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11
77
1.65
0.55
3.3
2.9
u/l
40.9
29.6
0.24
11
70
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
19
224
0.63
0.52
6.2
5.6
mmol/mol
41.2
39.7
0.24
19
207
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7
103
0.59
0.50
3.9
5.5
ug/l
1.3
2.1
—
7
85
(3020564) Creatinine [Moles/volume] in Serum or Plasma
24
262
0.66
0.46
18.7
15.6
umol/l
67.3
77.5
2.95
24
262
(3042936) Bacteria identified in Isolate by Culture
5
34
1.56
0.42
1.2
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.6
—
0.9
—
0
11
(3017732) Neutrophils [#/volume] in Blood
0
18
0.00
0.41
0.0
3.0
—
3.4
—
0
13
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
12
147
0.71
0.33
3.7
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
12
96
1.40
0.30
1.8
1.8
pmol/l
101.1
94.8
—
5
59
(3020682) Albumin/Creatinine [Ratio] in Urine
5
69
0.67
0.30
5.0
3.3
mg/mmol
1.0
12.4
—
5
47
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
87
1.40
0.29
3.1
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
9
113
0.72
0.25
6.2
3.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
19
168
1.32
0.24
6.8
4.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
11
0.00
0.22
0.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
6
51
1.22
0.21
2.8
4.8
—
1.0
—
0
7
(4035726)
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
57
1.29
0.20
4.6
4.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
7
60
1.21
0.19
2.9
5.4
—
—
—
0
0
(3015736) pH of Urine
11
92
1.30
0.19
4.1
4.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5
67
0.70
0.19
2.2
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
5
65
0.73
0.19
2.4
1.6
mmol/l
1.3
1.4
—
5
55
(36304419) Bacteria [Presence] in Urine
8
67
1.26
0.19
3.5
2.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
24
252
0.81
0.19
20.4
14.4
mmol/l
4.0
4.0
0.46
24
247
(40761511) CBC panel - Blood by Automated count
24
250
0.84
0.18
20.0
13.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
10
113
0.83
0.10
4.2
4.5
estimate
—
0.0
—
0
21
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
6
57
1.06
0.09
1.0
1.2
—
1.5
—
0
13
(3044640) Blood type and Crossmatch panel - Blood
8
76
1.07
0.08
3.8
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
9
84
1.10
0.08
3.2
6.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
20
190
1.14
0.06
24.9
15.7
%
14.0
13.7
0.25
20
185
(3009542) Hematocrit [Volume Fraction] of Blood
22
217
1.04
0.00
24.0
13.9
%
39.7
39.6
0.02
14
152
(3044889) 12 lead EKG panel
15
154
0.95
0.00
3.6
4.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
5
55
0.89
0.00
2.0
4.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
6
0.00
0.00
0.0
1.7
—
100.2
—
0
6
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.8
—
181.6
—
0
5
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
5
58
0.84
0.00
1.6
1.6
nmol/l
11.1
18.9
—
5
52
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4094501)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
6
59
1.02
0.00
2.5
2.5
—
7.4
—
0
7
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
13.2
—
0
6
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.3
—
156.7
—
0
9
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4306422)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
51.5
—
0
6
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
83
0.95
0.00
2.9
4.9
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_ASPHYXIATION – Asphyxiation
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).